First Quarter 2024

Earnings Results

April 30, 2024

Providing innovative chemical solutions for a cleaner, healthier, more energy efficient world.

Cautionary Statement

Certain information in this presentation consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company's plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "guidance," "predict," "potential," "continue," "likely," "will," "would," "should," "illustrative" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.

There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this presentation. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to disruptions in production or accidents at manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws; our ability to make acquisitions of suitable candidates and successfully integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including currency exchange rate fluctuations, legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to access capital markets; global political, military, security or other instability; costs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain its executive management and key personnel; and our debt covenants.

These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

2

Earnings Conference Call Agenda

2024 First Quarter Highlights

Scott R. Behrens, President & Chief Executive Officer

2024 First Quarter Financial Results

Luis E. Rojo, Vice President & Chief Financial Officer

Strategic Outlook

Scott R. Behrens, President & Chief Executive Officer

Analysts Q&A Session

Closing Remarks

Scott R. Behrens, President & Chief Executive Officer

3

First Quarter 2024 Highlights

NET

INCOME

DOWN

Reported Net

Income was $13.9

million and

Adjusted Net Income(1) was $14.7 million, down 11% year- over-year mainly due to a higher effective tax rate.

EBITDA(2) GROWTH

EBITDA(2) of $50.2

million and

Adjusted

EBITDA(2) of $51.2

million, up 5%

year-over-year.

VOLUME

GROWTH

Volume grew 1%

year-over-year with

growth in several end markets being offset by continued destocking in Agricultural Chemicals. Excluding declines in Agricultural Chemicals and Commodity Phthalic Anhydride, Volume was up +4%.

POSITIVE

CASH

FLOW

Generated Cash from Operations of $41.6 million and Positive Free Cash Flow (FCF(3)) of $11.4 million, up $175.6 million versus Q1 2023 as

capital

expenditures

returned to

historical levels.

COST OUT ON TRACK

Company is on

track to deliver the

$50 million cost

reduction goal for

2024 through

disciplined efforts

in supply chain,

and the benefit of

the Q4 2023

workforce

productivity

actions.

  1. Adjusted Net Income is a Non-GAAP measure that excludes certain significant, non-recurring items. See Appendix II for a GAAP reconciliation.
  2. EBITDA and Adjusted EBITDA are Non-GAAP measures. See Appendix III for GAAP reconciliations.
  3. Free Cash Flow is a Non-GAAP measure. See Appendix V for a GAAP reconciliation.

4

Net Income Bridge - Q1 2023 to Q1 2024

$0.71

$0.64

Adj. EPS

Adj. EPS

Note: All amounts are in millions of U.S. dollars and are reported after-tax.

  1. The adjustments to Reported Net Income in Q1 2023 consisted of environmental remediation expense and restructuring costs of $0.4 million, deferred compensation expense and cash-settled SARs income of $0.1 million.
  2. Adjusted Net Income and Adjusted EPS are Non-GAAP measures that exclude certain significant, non-recurring items. See Appendix II for GAAP reconciliations.
  3. The adjustments to Reported Net Income in Q1 2024 consisted of environmental remediation expense of $1.2 million and deferred compensation income of $0.4 million

5

Adjusted EBITDA(1) Bridge - Q1 2023 to Q1 2024

Note: All amounts are in millions of U.S. dollars.

  1. Adjusted EBITDA is a Non-GAAP measure. See Appendix III for GAAP reconciliations.

Surfactants Adjusted EBITDA growth was driven by margin improvement, partially offset by higher expenses associated with our Pasadena facility and expenses associated with operational interruptions at the Millsdale plant site

Polymers results decreased mainly as a result of expenses associated with operational interruptions at our Millsdale site

Specialty Products results increased due to margin recovery and higher MCT product line end market demand

Corporate expenses were down primarily due to cost reduction activities, partially offset by higher incentive-based compensation accruals

6

Global Surfactants

Q1 2023 to Q1 2024 Net Sales Bridge

Volume was driven by share recovery in Mexico and double-digit growth in Personal Care, Oilfield, and to our Distribution partners, offset by continued Agricultural Chemicals destocking.

Price/ Mix was impacted by the pass-through of lower raw material cost, less favorable product and mix, and competitive pressure in Latin America and Europe.

F/ X positively impacted net sales by 2%.

Q1 2023 to Q1 2024 Adjusted EBITDA(1) Bridge

  1. Adjusted EBITDA is a Non-GAAP measure. See Appendix III for GAAP reconciliations.

North America and Asia benefitted from improved margins and higher Personal Care (including Low 1,4 Dioxane products) and Oilfield end market demand. This was offset by continued destocking in Agricultural Chemicals and overall lower demand in commodity Laundry end markets. Higher expenses related to our Pasadena facility and expenses and the impact of operational interruptions at the Millsdale site adversely impacted results.

Latin America results were driven by business recovery in Mexico and new contracted business for amphoterics, partially offset by continued destocking in Agricultural Chemicals and competitive pressure in Brazil.

Europe results decreased primarily due to destocking in Agricultural

Chemicals. Lower commodity Laundry end market demand and

7

competitive pressure also contributed to the lower results.

Global Polymers

Q1 2023 to Q1 2024 Net Sales Bridge

Volume growth was driven by Rigid and Specialty Polyols, up 4% and 7% respectively. Growth was geographically broad (US, Europe and Asia).

Price/ Mix was impacted by the contracted pass-through of lower raw material costs and the impact of lower commodity PA volume.

F/ X positively impacted net sales by 3%.

Q1 2023 to Q1 2024 Adjusted EBITDA(1) Bridge

  1. Adjusted EBITDA is a Non-GAAP measure. See Appendix III for GAAP reconciliations.

North America results were driven by higher volume in the Rigid Polyol and Specialty Polyol businesses and improved margins, which was mostly offset by lower Phthalic Anhydride volume and higher expenses related to the impact from operational interruptions at the Millsdale site.

Europe results decreased due to slightly lower margins, partially offset by higher sales volume in the Rigid Polyol and Specialty Polyol businesses.

Asia results benefitted from double-digit volume growth and margin expansion.

8

Balance Sheet & Cash Flow

Net Debt(1) / TTM Adjusted EBITDA(2) ($MM)Capital Expenditures ($MM)

2.9

Net

Debt/TTM

Adj EBITDA

Ratio(3)

520

183

Net Debt(1)

TTM Adjusted

EBITDA(2)

Cash from Operations ($MM)

175

161

42

(72)

2022

2023

Q1 2023

Q1 2024

  1. Net Debt is a Non-GAAP measure. See Appendix VI for a GAAP reconciliation.
  2. TTM Adjusted EBITDA is a Non-GAAP measure. See Appendix IV for a GAAP

reconciliation.

Free Cash Flow(4) ($MM)

(3)Net Debt / TTM Adjusted EBITDA Ratio is a Non-GAAP measure. See Appendix

9

VI for a GAAP reconciliation.

  1. Free Cash Flow is a Non-GAAP measure. See Appendix V for a GAAP reconciliation

Stepan Strategic Priorities & Growth Strategy

Creating and Delivering

Shareholder Value

Customer Intimacy & Extended Reach

• Focused Growth with Strategic Tier 1 Customers

• Grow Share of Wallet and expand Tier 2 & 3

Customer Base

Efficient Capital Allocation

Priority Market Diversification

• Agricultural Chemicals

• Continue Investing for Long

• Oilfield Chemicals

Term Growth

• HI&I

• Returning Cash to Shareholders

• Specialty Alkoxylation

• Inorganic Growth (M&A)

• Rigid Polyol including Spray Foam

SHAREHOLDER

VALUE CREATION

Cost & Operational Excellence

Innovation & Sustainability

• Safe and Efficient Manufacturing

• World Class R&D Capabilities

• Asset Reliability

• Broad Portfolio of Sustainable

• Cost Reduction

Technologies & Products

• Productivity Gains

• Strategic Development

Programs with Customers

10

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Stepan Company published this content on 30 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 April 2024 11:29:04 UTC.